| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |